Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Takuya, Inagaki"'
Autor:
Takuya Inagaki, Satoshi Taniguchi, Yasuhiro Kawai, Takahiro Maeki, Eri Nakayama, Shigeru Tajima, Haruko Takeyama, Chang Kweng Lim, Masayuki Saijo
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Zika virus (ZIKV) is a mosquito-borne flavivirus that causes febrile illness. The recent spread of ZIKV from Asia to the Americas via the Pacific region has revealed unprecedented features of ZIKV, including transplacental congenital infecti
Externí odkaz:
https://doaj.org/article/09300819fd214340ae09e4b3ec6fa69e
Autor:
Miho Shibamura, Tomoki Yoshikawa, Souichi Yamada, Takuya Inagaki, Phu Hoang Anh Nguyen, Hikaru Fujii, Shizuko Harada, Shuetsu Fukushi, Akira Oka, Masashi Mizuguchi, Masayuki Saijo
Publikováno v:
Virology Journal, Vol 17, Iss 1, Pp 1-10 (2020)
Abstract Background Human cytomegalovirus (HCMV) causes asymptomatic infections, but also causes congenital infections when women were infected with HCMV during pregnancy, and life-threatening diseases in immunocompromised patients. To better underst
Externí odkaz:
https://doaj.org/article/3b27c11fff6345fdb0ee4cbd431e5cd0
Autor:
Eri Nakayama, Fumihiro Kato, Shigeru Tajima, Shinya Ogawa, Kexin Yan, Kenta Takahashi, Yuko Sato, Tadaki Suzuki, Yasuhiro Kawai, Takuya Inagaki, Satoshi Taniguchi, Thuy T Le, Bing Tang, Natalie A Prow, Akihiko Uda, Takahiro Maeki, Chang-Kweng Lim, Alexander A Khromykh, Andreas Suhrbier, Masayuki Saijo
Publikováno v:
PLoS Pathogens, Vol 17, Iss 7, p e1009788 (2021)
Zika virus (ZIKV) strains are classified into the African and Asian genotypes. The higher virulence of the African MR766 strain, which has been used extensively in ZIKV research, in adult IFNα/β receptor knockout (IFNAR-/-) mice is widely viewed as
Externí odkaz:
https://doaj.org/article/e024fd1364a14127995d1117c6332511
Publikováno v:
The Journal of the Japanese Association for Chest Surgery. 37:93-98
Autor:
Tomoki Yoshikawa, Satoshi Taniguchi, Hirofumi Kato, Naoko Iwata-Yoshikawa, Hideki Tani, Takeshi Kurosu, Hikaru Fujii, Natsumi Omura, Miho Shibamura, Shumpei Watanabe, Kazutaka Egawa, Takuya Inagaki, Satoko Sugimoto, Supranee Phanthanawiboon, Shizuko Harada, Souichi Yamada, Shuetsu Fukushi, Shigeru Morikawa, Noriyo Nagata, Masayuki Shimojima, Masayuki Saijo
Publikováno v:
PLoS Pathogens, Vol 17, Iss 2, p e1008859 (2021)
Severe fever with thrombocytopenia syndrome (SFTS) caused by a species Dabie bandavirus (formerly SFTS virus [SFTSV]) is an emerging hemorrhagic infectious disease with a high case-fatality rate. One of the best strategies for preventing SFTS is to d
Externí odkaz:
https://doaj.org/article/5468716f2b8546b7981d0f71289fdc08
Publikováno v:
The Journal of the Japanese Association for Chest Surgery. 36:815-820
Autor:
Miho, Shibamura, Souichi, Yamada, Tomoki, Yoshikawa, Takuya, Inagaki, Phu Hoang Anh, Nguyen, Hikaru, Fujii, Shizuko, Harada, Shuetsu, Fukushi, Akira, Oka, Masashi, Mizuguchi, Masayuki, Saijo
Publikováno v:
Japanese Journal of Infectious Diseases. 75:496-503
Neutralizing antibodies (NAbs) to human cytomegalovirus (HCMV) are associated with the risk of transplacental HCMV infection of the fetus in pregnant women. The IgG-positivity rate to HCMV determined by enzyme immunoassay (EIA) or indirect immunofluo
Autor:
Shigeru Tajima, Satoshi Taniguchi, Eri Nakayama, Takahiro Maeki, Takuya Inagaki, Masayuki Saijo, Chang Kweng Lim
Publikováno v:
Vaccines, Vol 9, Iss 10, p 1077 (2021)
Genotype V (GV) Japanese encephalitis virus (JEV) has emerged in Korea and China since 2009. Recent findings suggest that current Japanese encephalitis (JE) vaccines may reduce the ability to induce neutralizing antibodies against GV JEV compared to
Externí odkaz:
https://doaj.org/article/b40153b556934b5cb8d486df8c71d559
Autor:
Hirofumi Kato, Mutsuyo Takayama-Ito, Itoe Iizuka-Shiota, Shuetsu Fukushi, Guillermo Posadas-Herrera, Madoka Horiya, Masaaki Satoh, Tomoki Yoshikawa, Souichi Yamada, Shizuko Harada, Hikaru Fujii, Miho Shibamura, Takuya Inagaki, Kinjiro Morimoto, Masayuki Saijo, Chang-Kweng Lim
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0223684 (2019)
Middle East respiratory syndrome-coronavirus (MERS-CoV) is an emerging virus that causes severe disease with fatal outcomes; however, there are currently no approved vaccines or specific treatments against MERS-CoV. Here, we developed a novel bivalen
Externí odkaz:
https://doaj.org/article/8ae36a7f037f43a1bce9f1f70f5f9b5e
Autor:
Mitsuyoshi Urashima, Yo Tsukamoto, Shohei Mori, Hisatoshi Asano, Takuya Inagaki, Mitsuo Yabe, Makoto Yamashita, Noriki Kamiya, Takeo Nakada, Makoto Odaka, Toshiaki Morikawa, Tadashi Akiba
Purpose: Higher serum 25-hydroxyvitamin D (25(OH)D) levels are reportedly associated with better survival in early-stage non–small cell lung cancer (NSCLC). Therefore, whether vitamin D supplementation can improve the prognosis of patients with NSC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e4c477596e5a6fc3b742f5527ad5104
https://doi.org/10.1158/1078-0432.c.6527553.v1
https://doi.org/10.1158/1078-0432.c.6527553.v1